drugset / Trial / NCT06324825

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

NCT06324825 ↗

Unknown 144 enrolled Peking University First Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.

Timeline

Start
2022-10-24
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fuzheng Nizeng Formula Unknown — —
Comparator Moluodan granules Unknown 9 g —